Of the 71 patients in the study, 42 were men, 53 were Caucasian, 50 had nonischemic cardiomyopathy, and the diagnosis was confirmed in 66 of the 71 patients via cardiac catheterization (n=52) or ...
The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...
Ventricular resection can significantly improve your life span if you have severe heart failure due to an enlarged left ventricle. If you have an enlarged heart (also known as cardiomegaly), it means ...
Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025 and simultaneously published in The Lancet VERQUVO was ...
An investigational material known Bioabsorbable Cardiac Matrix (BCM) that is injected through the coronary artery to prevent cardiac remodelling in heart attack patients had no significant effect ...
Credit: Getty Images A 65-year-old woman presents to her primary care provider with a chief complaint of "feeling winded" for the last 3 weeks. A 65-year-old woman presents to her primary care ...
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback